Post-approval studies (Phase 4)Study completedNCT04995029
What this trial is testing
Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
Who this might be right for
Moderate to Severe Opioid-use Disorder
Indivior Inc. 785